Edwards Lifesciences
Delayed Nyse - 02/16 10:02:02 pm
Healthcare Services
 Healthcare Equipment & Supplies
  Advanced Medical Equipment & Technology
   Advanced Medical Equipment & Technology - NEC
Designs, develops, manufactures and markets products to treat late-stage cardiovascular disease

Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease.

It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World.

Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care.

The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve.

The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass.

The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques.

The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems.

The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts.

The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Sales per Businesses
(in Million)
(in Million)
Transcatheter Heart Valve Therapy1,18047.3%1,62954.9%
Surgical Heart Valve Therapy785.0031.5%774.9026.1%
Critical Care528.4021.2%560.3018.9%
Sales per Regions
(in Million)
(in Million)
United States1,26350.6%1,61654.5%
Rest of World267.3010.7%289.709.8%
- Chairman & Chief Executive Officer :
    Michael Mussallem
- Chief Financial Officer & Vice President :
    Scott Ullem
- Chief Scientific Officer & VP-Advanced Technology :
    Stanton Rowe
- Vice President-Quality, Regulatory & Clinical :
    John McGrath
- Independent Director :
    John Cardis
- Independent Director :
    William Link
- Independent Director :
    Wesley von Schack
- Independent Director :
    Nicholas Valeriani
- Independent Director :
    Kieran Gallahue
- Independent Director :
    Martha Marsh
Company contact information
1 way Edwards
CA 92614 Irvine, California
États-Unis (les)

Phone : +1 949 250 2500
Fax : +1 949 250 2525
Internet : http://www.edwards.com
Markets and indexes
- Main Market
- SP 500 /
Stock Exchange Codes
- ISIN Code :  US28176E1082
Overall rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
Yield -
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision